DOCSLIB.ORG

Appendix B: Authorization Guidelines for Outpatient Services (Auto Auth List) See the Following Page

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Appendix B: Authorization Guidelines for Outpatient Services (Auto Auth List) See the Following Page KAISER PERMANENTE OF OHIO Appendix B: Authorization Guidelines for Outpatient Services (Auto Auth List) See the following page. Kaiser Permanente Provider Manual APPENDIX B Revised June 2011 1 KAISER PERMANENTE OF OHIO KAISER PERMANENTE AUTO AUTH LIST HCPCS PRIMARY EFFECTIVE Code PROCEDURE DESCRIPTION SPECIALTY DATE ANESTHESIA FOR PROCEDURES IN LUMBAR REGION; NOT 00630 OTHERWISE SPECIFIED anes/rad 1/1/2007 ANESTHESIA FOR UPPER GASTROINTESTINAL ENDOSCOPIC PROCEDURES, ENDOSCOPE INTRODUCED PROXIMAL TO 00740 DUODENUM gastro 1/1/2007 ANESTHESIA FOR LOWER INTESTINAL ENDOSCOPIC PROCEDURES, ENDOSCOPE INTRODUCED DISTAL TO 00810 DUODENUM gastro 1/1/2006 ANESTHESIA FOR MYELOGRAPHY, DISKOGRAPHY, 01905 VERTEBROPLASTY radiology 1/1/2007 01916 ANESTHESIA FOR DIAGNOSTIC ARTERIOGRAPHY/VENOGRAPHY radiology 1/1/2007 ANESTHESIA FOR NON-INVASIVE IMAGING OR RADIATION 01922 THERAPY radiology 1/1/2006 ANESTHESIA FOR THERAPEUTIC INTERVENTIONAL RADIOLOGIC PROCEDURES INVOLVING THE ARTERIAL SYSTEM; NOT 01924 OTHERWISE SPECIFIED radiology 1/1/2006 ANESTHESIA FOR THERAPEUTIC INTERVENTIONAL RADIOLOGIC PROCEDURES INVOLVING THE ARTERIAL SYSTEM; CAROTID OR 01925 CORONARY radiology 1/1/2006 ANESTHESIA FOR THERAPEUTIC INTERVENTIONAL RADIOLOGIC PROCEDURES INVOLVING THE ARTERIAL SYSTEM; 01926 INTRACRANIAL, INTRACARDIAC, OR AORT radiology 1/1/2006 ANESTHESIA FOR THERAPEUTIC INTERVENTIONAL RADIOLOGIC PROCEDURES INVOLVING THE VENOUS/LYMPHATIC SYSTEM 01930 (NOT TO INCLUDE ACCESS TO TH radiology 1/1/2006 REGIONAL INTRAVENOUS ADMINISTRATION OF LOCAL ANESTHETIC AGENT OR OTHER MEDICATION (UPPER OR 01995 LOWER EXTREMITY) general 1/1/2006 10021 FINE NEEDLE ASPIRATION; WITHOUT IMAGING GUIDANCE general 1/1/2005 INCISION AND DRAINAGE OF ABSCESS (EG, CARBUNCLE, SUPPURATIVE HIDRADENITIS, CUTANEOUS OR SUBCUTANEOUS 10060 ABSCESS, CYST, FURUNCLE, OR P general 1/1/2005 INCISION AND DRAINAGE OF ABSCESS (EG, CARBUNCLE, SUPPURATIVE HIDRADENITIS, CUTANEOUS OR SUBCUTANEOUS 10061 ABSCESS, CYST, FURUNCLE, OR P general 1/1/2005 10080 INCISION AND DRAINAGE OF PILONIDAL CYST; SIMPLE general 1/1/2006 INCISION AND REMOVAL OF FOREIGN BODY, SUBCUTANEOUS 10120 TISSUES; SIMPLE general 1/1/2005 PUNCTURE ASPIRATION OF ABSCESS, HEMATOMA, BULLA, OR 10160 CYST general 1/1/2005 DEBRIDEMENT OF EXTENSIVE ECZEMATOUS OR INFECTED 11000 SKIN; UP TO 10% OF BODY SURFACE surg 1/1/2005 DEBRIDEMENT OF EXTENSIVE ECZEMATOUS OR INFECTED SKIN; EACH ADDITIONAL 10% OF THE BODY SURFACE (LIST 11001 SEPARATELY IN ADDITION TO CODE surg 1/1/2005 11040 DEBRIDEMENT; SKIN, PARTIAL THICKNESS surg 1/1/2005 11041 DEBRIDEMENT; SKIN, FULL THICKNESS surg 1/1/2005 Kaiser Permanente Provider Manual APPENDIX B Revised June 2011 2 KAISER PERMANENTE OF OHIO KAISER PERMANENTE AUTO AUTH LIST HCPCS PRIMARY EFFECTIVE Code PROCEDURE DESCRIPTION SPECIALTY DATE 11042 DEBRIDEMENT; SKIN, AND SUBCUTANEOUS TISSUE surg 1/1/2005 11043 DEBRIDEMENT; SKIN, SUBCUTANEOUS TISSUE, AND MUSCLE surg 1/1/2005 DEBRIDEMENT; SKIN, SUBCUTANEOUS TISSUE, MUSCLE, AND 11044 BONE surg 1/1/2005 BIOPSY OF SKIN, SUBCUTANEOUS TISSUE AND/OR MUCOUS MEMBRANE (INCLUDING SIMPLE CLOSURE), UNLESS 11100 OTHERWISE LISTED; SINGLE LESION surg 1/1/2005 BIOPSY OF SKIN, SUBCUTANEOUS TISSUE AND/OR MUCOUS MEMBRANE (INCLUDING SIMPLE CLOSURE), UNLESS 11101 OTHERWISE LISTED; EACH SEPARATE/ADDI surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, 11300 TRUNK, ARMS OR LEGS; LESION DIAMETER 0.5 CM OR LESS surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, 11301 TRUNK, ARMS OR LEGS; LESION DIAMETER 0.6 TO 1.0 CM surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, 11302 TRUNK, ARMS OR LEGS; LESION DIAMETER 1.1 TO 2.0 CM surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, 11303 TRUNK, ARMS OR LEGS; LESION DIAMETER OVER 2.0 CM surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.5 11305 CM OR LESS surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.6 11306 TO 1.0 CM surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 1.1 11307 TO 2.0 CM surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 11308 OVER 2.0 CM surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; 11310 LESION DIAMETER 0.5 CM OR surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; 11311 LESION DIAMETER 0.6 TO 1.0 surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; 11312 LESION DIAMETER 1.1 TO 2.0 surg 1/1/2005 SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; 11313 LESION DIAMETER OVER 2.0 C surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; 11400 EXCISED DIAMETER 0.5 CM surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; 11401 EXCISED DIAMETER 0.6 TO surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN 11402 TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; surg 1/1/2005 Kaiser Permanente Provider Manual APPENDIX B Revised June 2011 3 KAISER PERMANENTE OF OHIO KAISER PERMANENTE AUTO AUTH LIST HCPCS PRIMARY EFFECTIVE Code PROCEDURE DESCRIPTION SPECIALTY DATE EXCISED DIAMETER 1.1 TO EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; 11403 EXCISED DIAMETER 2.1 TO surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; 11404 EXCISED DIAMETER 3.1 TO surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; 11406 EXCISED DIAMETER OVER 4 surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, 11420 FEET, GENITALIA; EXCISED surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, 11421 FEET, GENITALIA; EXCISED surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, 11422 FEET, GENITALIA; EXCISED surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, 11423 FEET, GENITALIA; EXCISED surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, 11424 FEET, GENITALIA; EXCISED surg 1/1/2005 EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, 11426 FEET, GENITALIA; EXCISED surg 1/1/2005 EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, 11440 EYELIDS, NOSE, LIPS, MUCOU surg 1/1/2005 EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, 11441 EYELIDS, NOSE, LIPS, MUCOU surg 1/1/2005 EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, 11442 EYELIDS, NOSE, LIPS, MUCOU surg 1/1/2005 EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, 11443 EYELIDS, NOSE, LIPS, MUCOU surg 1/1/2005 EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, 11444 EYELIDS, NOSE, LIPS, MUCOU surg 1/1/2005 EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, 11446 EYELIDS, NOSE, LIPS, MUCOU surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, 11600 ARMS, OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, 11601 ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM surg 1/1/2005 Kaiser Permanente Provider Manual APPENDIX B Revised June 2011 4 KAISER PERMANENTE OF OHIO KAISER PERMANENTE AUTO AUTH LIST HCPCS PRIMARY EFFECTIVE Code PROCEDURE DESCRIPTION SPECIALTY DATE EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, 11602 ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, 11603 ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, 11604 ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, 11606 ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR 11620 LESS surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 11621 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 11622 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 11623 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 11624 CM surg 1/1/2005 EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 11626 CM surg 1/1/2005 EXCISION, MALIGNANT LESION
Load more

Recommended publications
  • Anorectal Disorders Satish S
    Gastroenterology 2016;150:1430–1442 Anorectal Disorders Satish S. C. Rao,1 Adil E. Bharucha,2 Giuseppe Chiarioni,3,4 Richelle Felt-Bersma,5 Charles Knowles,6 Allison Malcolm,7 and Arnold Wald8 1Division of Gastroenterology and Hepatology, Augusta University, Augusta, Georgia; 2Department of Gastroenterology and Hepatology, Mayo College of Medicine, Rochester, Minnesota; 3Division of Gastroenterology of the University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; 4Division of Gastroenterology and Hepatology and UNC Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 5Department of Gastroenterology/Hepatology, VU Medical Center, Amsterdam, The Netherlands; 6National Centre for Bowel Research and Surgical Innovation, Blizard Institute, Queen Mary University of London, London, United Kingdom; 7Division of Gastroenterology, Royal North Shore Hospital, and University of Sydney, Sydney, Australia; 8Division of Gastroenterology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin This report defines criteria and reviews the epidemiology, questionnaires and bowel diaries are correlated,5 some pathophysiology, and management of the following com- patients may not accurately recall bowel symptoms6; hence, mon anorectal disorders: fecal incontinence (FI), func- symptom diaries may be more reliable. tional anorectal pain, and functional defecation disorders. In this report, we examine the prevalence and patho- FI is defined as the recurrent uncontrolled passage of fecal physiology of anorectal disorders, listed in Table 1,and material for at least 3 months. The clinical features of FI provide recommendations for diagnostic evaluation and are useful for guiding diagnostic testing and therapy. management. These supplement practice guidelines rec- ANORECTAL Anorectal manometry and imaging are useful for evalu- ommended by the American Gastroenterological Associa- fl ating anal and pelvic oor structure and function.
    [Show full text]
  • Reoperative Techniques and Management in Hirschsprung Disease: a Narrative Review
    14 Review Article Reoperative techniques and management in Hirschsprung disease: a narrative review Farokh R. Demehri^, Belinda H. Dickie Department of Surgery, Boston Children’s Hospital, Boston, MA, USA Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors Correspondence to: Farokh R. Demehri, MD. Department of Surgery, Boston Children’s Hospital, 300 Longwood Ave, Fegan 3, Boston, MA 02115, USA. Email: [email protected]. Abstract: The majority of children who undergo operative management for Hirschsprung disease have favorable results. A subset of patients, however, have long-term dysfunctional stooling, characterized by either frequent soiling or obstructive symptoms. The evaluation and management of a child with poor function after pull-through for Hirschsprung disease should be conducted by an experienced multidisciplinary team. A systematic workup is focused on detecting pathologic and anatomic causes of pull- through dysfunction. This includes an exam under anesthesia, pathologic confirmation including a repeat biopsy, and a contrast enema, with additional studies depending on the suspected etiology. Obstructive symptoms may be due to technique-specific types of mechanical obstruction, histopathologic obstruction, or dysmotility—each of which may benefit from reoperative surgery. The causes of soiling symptoms include loss of the dentate line and damage to the anal sphincter, which generally do not benefit from revision of the pull-through, and pseudo-incontinence, which may reveal underlying obstruction. A thorough understanding of the types of complications associated with various pull-through techniques aids in the evaluation of a child with postoperative dysfunction.
    [Show full text]
  • Guidelines for the Management of Postoperative Soiling in Children with Hirschsprung Disease
    Pediatric Surgery International (2019) 35:829–834 https://doi.org/10.1007/s00383-019-04497-y REVIEW ARTICLE Guidelines for the management of postoperative soiling in children with Hirschsprung disease P. Saadai1,2 · A. F. Trappey1,2 · A. M. Goldstein3 · R. A. Cowles4 · L. De La Torre5 · M. M. Durham6 · E. Y. Huang7 · M. A. Levitt8 · K. Rialon9 · M. Rollins10 · D. H. Rothstein11 · J. C. Langer9 on behalf of The American Pediatric Surgical Association Hirschsprung Disease Interest Group Accepted: 6 June 2019 / Published online: 14 June 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Although most children with Hirschsprung disease ultimately achieve functional and comfortable stooling, some will experi- ence a variety of problems after pull-through surgery. The most common problems include soiling, obstructive symptoms, enterocolitis, and failure to thrive. The purpose of this guideline is to present a rational approach to the management of postoperative soiling in children with Hirschsprung disease. The American Pediatric Surgical Association Hirschsprung Disease Interest Group engaged in a literature review and group discussions. Expert consensus was then used to summarize the current state of knowledge regarding causes, methods of diagnosis, and treatment approaches to children with soiling symptoms following pull-through for Hirschsprung disease. Causes of soiling after pull-through are broadly categorized as abnormalities in sensation, abnormalities in sphincter control, and “pseudo-incontinence.” A stepwise algorithm for the diagnosis and management of soiling after a pull-through for Hirschsprung disease is presented; it is our hope that this rational approach will facilitate treatment and optimize outcomes. Keywords Hirschsprung disease · Soiling · Incontinence · Pseudo-incontinence · Bowel management · Pull-through Background obstructive symptoms, enterocolitis and failure to thrive [1].
    [Show full text]
  • DIGESTIVE DISEASE CENTER University Hospital of Brooklyn • Long Island College Hospital • SUNY Downstate Bay Ridge
    SUNY DowNState MeDical ceNter DIGESTIVE DISEASE CENTER University Hospital of Brooklyn • long island college Hospital • SUNY Downstate Bay ridge 2012-13 comPreHensiVe Gi serVices GENERAL ADVANCED ENDOSCOPY The Digestive Disease Center at SUNY Downstate GASTROENTEROLOGY Endoscopy allows for direct internal examination and much more accurate diagnosis and treatment of digestive and liver Medical Center provides expertise in all aspects of problems, without invasive surgical procedures. At our state-of-the-art Endoscopy Center, patients have access to virtually gastrointestinal disease management, including: In addition to routine colorectal screenings, we provide every available endoscopic, manometric and treatment option—plus some investigational diagnostic and therapeutic diagnoses and treatment for a wide range of medical procedures not available elsewhere. Medical Director Frank Gress is one of the pioneers of endoscopic ultrasound and General Gastroenterology problems related to the stomach, intestinal tract, biliary literally wrote a textbook on the procedure. tract, gallbladder, bowel and liver, including: Colorectal Cancer Screening Full range of advanced diagnostic and therapeutic endoscopic services: I Colon polyps and colon cancer Advanced Endoscopy I Endoscopic retrograde cholangiopancreatography (ERCP). I Constipation I Sphincter of Oddi manometry (SOD). Pancreaticobiliary Disease I GI bleeding I Endoscopic ultrasound with fine-needle aspiration (EUS FNA). Esophageal and Motility Disorders I Hemorrhoids I I Colonic stents, esophageal stents, small bowel stents and other stent placement Inflammatory Bowel Disease Irritable bowel syndrome for palliative purposes. I Hepatitis & Other Liver Diseases Chronic diarrheal disorder I Small bowel enteroscopy to evaluate gastrointestinal bleeding. I Peptic ulcer disease Pediatric Gastroenterology I Video capsule endoscopy. I Rectal incontinence I Gastrointestinal Radiology EMR, BARRx and photodynamic therapy.
    [Show full text]
  • Clinical Evaluation of a Patient with Symptoms of Colonic Or Anorectal Motility Disorders
    J Neurogastroenterol Motil, Vol. 26 No. 4 October, 2020 pISSN: 2093-0879 eISSN: 2093-0887 https://doi.org/10.5056/jnm20012 JNM Journal of Neurogastroenterology and Motility Technique Review Clinical Evaluation of a Patient With Symptoms of Colonic or Anorectal Motility Disorders Bryan Curtin, Enoe Jimenez, and Satish S C Rao* Division of Gastroenterology and Hepatology, Digestive Health Center, Augusta University, Medical College of Georgia, Augusta, GA, USA Constipation, irritable bowel syndrome, fecal incontinence, abdominal pain, and anorectal pain are problems that affect 40% of the population. They commonly present with overlapping symptoms indicating that their pathophysiology affects multiple segments of the gut as well as brain and gut interactions. Clinically, although some conditions are readily recognized, dyssynergic defecation, fecal incontinence, and anorectal pain are often missed or misdiagnosed. Consequently, the assessment of lower gastrointestinal symptoms in patients with suspected colonic or anorectal motility disorder(s) remains challenging for most clinicians. A detailed history, use of the Bristol stool form scale, prospective stool diaries, ideally through a phone App, digital rectal examination, and judicious use of complementary diagnostic tests are essential. Additionally, it is important to evaluate the impact of these problems on quality of life and psychosocial issues, because they are intricately linked with these disorders. The Rome IV diagnostic questionnaire for functional gastrointestinal disorders can provide additional information often missed during history taking. Here, we discuss a systematic approach for the clinical evaluation of patients with suspected lower gastrointestinal problems, grouped under 4 common diagnostic categories. We describe how to take a detailed history, perform meticulous digital rectal examination, and use validated tools to supplement clinical evaluation, including assessments of quality of life and scoring systems for disease severity and digital Apps.
    [Show full text]
  • The Prevalence of Enteropathy Symptoms from the Lower Gastrointestinal Tract and the Evaluation of Anorectal Function in Diabetes Mellitus Patients
    Journal of Clinical Medicine Article The Prevalence of Enteropathy Symptoms from the Lower Gastrointestinal Tract and the Evaluation of Anorectal Function in Diabetes Mellitus Patients Małgorzata Reszczy ´nska 1,* and Radosław Kempi ´nski 2 1 Department of Gastroenterology and Hepatology, Wrocław University Hospital, 50-556 Wrocław, Poland 2 Department of Gastroenterology and Hepatology, Wrocław Medical University, 50-367 Wrocław, Poland; [email protected] * Correspondence: [email protected] Abstract: Complications affecting the gastrointestinal tract often occur in the course of diabetes mellitus (DM). The aim of this study was to evaluate enteropathy symptoms and anorectal function using high-resolution anorectal manometry (HRAM). Fifty DM patients and 20 non-DM controls were enrolled into the study. Clinical data and laboratory tests were collected, physical examination and HRAM were performed. Symptoms in the lower gastrointestinal tract were reported by 72% of patients. DM patients with a long disease duration reported anal region discomfort (p = 0.028) and a sensation of incomplete evacuation (p = 0.036) more often than patients with shorter diabetes duration. Overall, DM patients had a lower maximal squeeze pressure (MSP) (p = 0.001) and a higher mean threshold of minimal rectal sensation (p < 0.01) than control subjects. They presented with enhanced features of dyssynergic defection than the control group. MSP and maximal resting pressure (MRP) were significantly lower in the group of long-term diabetes (p = 0.024; p = 0.026 respectively) than in patients with a short-term diabetes. The same observation was noted for patients with enteropathy symptoms that control for MSP (p < 0.01; p < 0.01; p = 0.03) and MRP (p < 0.001; p = 0.0036; p = 0.0046), Citation: Reszczy´nska,M.; respectively, for incontinence, constipation, and diarrhea.
    [Show full text]
  • Anorectal Manometry Results in Defecation Disorders
    Arch Dis Child: first published as 10.1136/adc.58.4.257 on 1 April 1983. Downloaded from Archives of Disease in Childhood, 1983, 58, 257-261 Anorectal manometry results in defecation disorders D MOLNAR, L S TAITZ, 0 M URWIN, AND J K H WALES Department ofPaediatrics, University of Sheffield, and Children's Hospital, Sheffield SUMMARY Anorectal manometry and suction biopsy were carried out on 47 children with con- stipation or soiling, or both. Patients were divided into two groups. Group 1 (37 patients): functional faecal retention, group 2 (10 patients): functional faecal soiling without retention. Ganglion cells or normal acetylcholinesterase staining, or both, was demonstrated in all cases. Normal inhibition of internal sphincter could be achieved by rectal distension in all except 2 children with severe constipation. Resting sphincteric pressures, pressure responses, and conscious rectal sensitivity thresholds were similar in groups 1 and 2, but were increased compared with controls. In group 1 alone, the critical volume increased parallel with conscious rectal sensitivity threshold. Since the complete relaxation of internal sphincter occurs before conscious rectal sensation arises in children with soiling without retention, this may be an important factor, at least in some of the soilers. Between 10 and 20% of children referred for (n=2), preoperative ureter implantation to bowel gastroenterological consultation have disorders of (n= 1), asymptomatic diastematomyelia (n= 1), defecation. Despite this there has been compara- irritable detrusor (n=1), preoperative vaginal tively little research. Consequently it is not clear surgery (n= 1), and postoperative bowel resection what investigations are necessary in children with (n= 1).
    [Show full text]
  • High Resolution Anorectal Manometry (MMS Catheter)
    STANDARD OPERATING PROCEDURE – High Resolution Anorectal Manometry (MMS Catheter) SOP Title How to perform High Resolution Anorectal Manometry (MMS Catheter) Author Dr. Henriette Heinrich Jan Willem Van der Waal (MMS) Reviewed by Prof. Mark Fox EUGIM-Hub SOP (MMS High Resolution Anorectal Manometry) Page 1 of 6 STANDARD OPERATING PROCEDURE – High Resolution Anorectal Manometry (MMS Catheter) 1. PURPOSE This SOP is designed to enable clinicians and researchers involved in the clinical investigation of anorectal motor and sensory function, to correctly perform, record and analyse the findings acquired using the MMS High Resolution Anorectal Manometry Catheter. 2. INTRODUCTION Anal manometry is the best established, most commonly performed test of anorectal sphincter function and recto- anal coordination. The advent of high-resolution manometry utilizing a higher number of closely spaced pressure sensors with data presented as colour-contour pressure topography plots, has revolutionized the field of gastrointestinal motility.1-4 3. SCOPE This SOP applies to all clinical staff including nurses and investigators who participate in the running of clinical studies of anorectal motor and sensory testing. 4. SPECIFIC PROCEDURE DESCRIPTION 1. Equipment: MMS Solid State catheter MMS Software MMS Manometry System Bowl with hand warm water 50 ml syringe 3 way tap Lucrication jelly Balloon (MMS) Tying material EUGIM-Hub SOP (MMS High Resolution Anorectal Manometry) Page 2 of 6 STANDARD OPERATING PROCEDURE – High Resolution Anorectal Manometry (MMS Catheter) 2. Potential Hazards and Safe Handling Ø Infection from unsuspected agents- HIV or Hepatitis faeces, blood or any other body fluids. 3. Safe handling Ø Wear disposable gloves. Gloves can be changed as often as necessary during the procedure to prevent contamination of equipment.
    [Show full text]
  • Documented Complications of Staple Hemorrhoidopexy: a Systematic Review
    Int Surg 2015;100:44–57 DOI: 10.9738/INTSURG-D-13-00173.1 Documented Complications of Staple Hemorrhoidopexy: A Systematic Review Liesel J. Porrett, Jemma K. Porrett, Yik-Hong Ho Townsville Hospital, Queensland, Australia A systematic review addressing reported complications of stapled hemorrhoidopexy was conducted. Articles were identified via searching OVID and MEDLINE between July 2011 and October 2013. Limitations were placed on the search criteria with articles published from 1998 to 2013 being included in this review. No language restrictions were placed on the search, however foreign language articles were not translated. Two reviewers independently screened the abstracts for relevance and their suitability for inclusion. Data extraction was conducted by both reviewers and entered and analyzed in Microsoft Excel. The search identified 784 articles and 78 of these were suitable for inclusion in the review. A total of 14,232 patients underwent a stapled hemorrhoidopexy in this review. Overall complication rates of stapled hemorrhoidopexy ranged from 3.3%– 81% with 5 mortalities documented. Early and late complications were defined individually with overall data suggesting that early complications ranged from 2.3%– 58.9% and late complications ranged from 2.5%–80%. Complications unique to the procedure were identified and rates recorded. Both early and late complications unique to stapled hemorrhoidopexy were identified and assessed. Key words: Stapled anopexy – Stapled hemorrhoidectomy – Stapled hemorrhoidopexy – Complications he stapled hemorrhoidopexy was introduced in postoperative outcomes, in comparison with the T 1993 and has been used as an alternative previously used methods. Despite this, however, method to the Ferguson and Milligan-Morgan long-term sequelae of the stapled hemorrhoidopexy technique for the surgical management of hemor- have not been widely documented and recent rhoidal disease.
    [Show full text]
  • Manometric Tests of Anorectal Function in 90 Healthy Children
    Journal of Pediatric Surgery (2009) 44, 1786–1790 www.elsevier.com/locate/jpedsurg Manometric tests of anorectal function in 90 healthy children: a clinical study from Kuwait Sunil Kumar⁎, Saleema Ramadan, Vipul Gupta, Safwat Helmy, Imran Atta, Ashraf Alkholy Department of Pediatric Surgery, Ibn Sina Hospital, P O Box 25427, Safat-13115, Kuwait, Kuwait Received 6 October 2008; revised 7 January 2009; accepted 7 January 2009 Key words: Abstract Rectoanal inhibitory Background/Purpose: Anorectal manometry is a noninvasive test used to evaluate conditions like slow- reflex, RAIR; transit constipation, anorectal outlet obstruction, and Hirschsprung disease and to assess postoperative Resting pressure of anal results after Hirschsprung and anorectal malformations. This cross section study was designed to have canal, RP; normal manometric values of anorectal function in healthy children of different ages in Kuwait so that High-pressure zone, HPZ; control values are available for comparisons with various pathological states. Anal canal length, ACl Method: Anorectal manometry was conducted in 90 children aged 3 days to 12 years without any symptoms related to lower gastrointestinal tract. They were divided in 3 age groups (group 1—neonates up to 1 month, group 2—infants from 1 month to 1 year, and group 3—children more than 1 year). Water perfused system with anorectal catheter with 4 side holes was used to record length of anal canal or high-pressure zone, resting pressure of anal canal, and rectoanal inhibitory reflex (RAIR). Result: Anorectal manometry was successfully done in all 90 children of different age groups with- out any complications. High-pressure zone or anal canal length was 1.67 ± 0.34 cm in neonates, 1.86 ± 0.6 cm in infants, and 3.03 ± 0.52 cm in children.
    [Show full text]
  • Clinical Investigations in Gastroenterology Third Edition Clinical Investigations in Gastroenterology Malcolm C
    Malcolm C. Bateson Ian A.D. Bouchier Clinical Investigations in Gastroenterology Third Edition Clinical Investigations in Gastroenterology Malcolm C. Bateson • Ian A.D. Bouchier Clinical Investigations in Gastroenterology Third Edition Malcolm C. Bateson Ian A.D. Bouchier Bishop Auckland Edinburgh, Midlothian United Kingdom United Kingdom ISBN 978-3-319-53785-6 ISBN 978-3-319-53786-3 (eBook) DOI 10.1007/978-3-319-53786-3 Library of Congress Control Number: 2017939629 © Springer International Publishing AG 1988, 1997, 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
    [Show full text]
  • Anorectal Manometry What Is Anorectal Manometry? Anorectal Manometry (Or ARM) Is a Diagnostic Test, Not a Treatment Or Intervention
    Anorectal Manometry What is anorectal manometry? Anorectal manometry (or ARM) is a diagnostic test, not a treatment or intervention. This test utilizes a catheter and a balloon to study the nerves and muscles of the anus and rectum. It tests pressures and sensations in the anus and rectum. The catheter is small, like a rectal thermometer. It is attached to a computer that records the pressures. The results look like a graph. The balloon contains latex, so please inform your doctor if your child is allergic to latex. Why might a child need anorectal manometry? This test is done in children with difficult to treat constipation, fecal incontinence (unable to stop stool from leaking), and abnormalities of the anus (anal malformations). The test is used to test the function of the anus and rectum. It tests whether children have normal sensation and are using their muscles correctly to hold and pass stool. It also helps to diagnose a condition called Hirschsprung disease. How is the anorectal manometry performed? A rectal examination is done before the test. A catheter with a balloon is passed through the anus to the rectum. The balloon is inflated and pressures and sensations are studied. The child may be asked to squeeze, cough and push the balloon out. The test may last from 15- 30 minutes. →→What happens before anorectal manometry is ​ performed? Give a Dulcolax (bisacodyl) suppository the night before the procedure. ​ What happens after anorectal manometry is performed? Immediately following the completion of the test most children are able to return home an​ d resume their daily activity.
    [Show full text]